Besremi 500 MCG/ML syringeml
Ended Awarded Last action
- Contract number
- SPE2DR26FS24Q
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,962
Award facts
- Contract value 100% obligated
- $26,962.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $26,962.20 delivery order to AmerisourceBergen Drug Corp on January 14, 2026, for the supply of Besremi 500 micrograms per milliliter in syringe form. This is a firm fixed-price, competitively awarded contract with an ultimate completion date of February 5, 2026, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's parent company, Cencora, Inc. (doing business as AmerisourceBergen), which holds a substantial Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 through December 31, 2031. This underlying IDC vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen is a major pharmaceutical distributor and critical federal medical procurement vendor that serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company has demonstrated significant capability in fulfilling federal pharmaceutical supply requirements through open competition, with an extensive portfolio of medical product deliveries spanning multiple therapeutic domains including specialty medications, brand-name and generic drugs, vaccines, and medical devices. No set-aside designation was applied to this award, reflecting the competitive nature of the procurement and AmerisourceBergen's established position as a qualified vendor within the federal supply chain.
Quick answers
Who was awarded contract SPE2DR26FS24Q?
SPE2DR26FS24Q was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26FS24Q worth?
The government has obligated $26,962 on SPE2DR26FS24Q.
Is contract SPE2DR26FS24Q an order under another contract?
Yes. SPE2DR26FS24Q is a delivery order under SPE2DR25D2204, an indefinite delivery contract.
Was contract SPE2DR26FS24Q competed?
The extent of competition for SPE2DR26FS24Q was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award